Hong Wang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Radical Prostatectomy

Dna Damage Response

Top Venues

Research square

Science (New York, N.Y.)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene 43 (11) (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene 43 (11) (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene 43 (11) (2024)
Qiming Wang, Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn Connelly, Hong Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Research square (2023)
Diwakar Davar, Roberta Zappasodi, Hong Wang, Girish S Naik, Takami Sato, Todd Bauer, David L Bajor, Olivier Rixe, Walter Newman, Jingjing Qi, Aliya Holland, Phillip Wong, Lianna Sifferlen, Diane Piper, Cynthia A Sirard, Taha Merghoub, Jedd D Wolchok, Jason John Luke
Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Diwakar Davar, Amiran K Dzutsev, John A McCulloch, Richard Rosario Rodrigues, Joe-Marc Chauvin, Robert M Morrison, Richelle N Deblasio, Carmine Menna, Quanquan Ding, Ornella Pagliano, Bochra Zidi, Shuowen Zhang, Jonathan H Badger, Marie Vetizou, Alicia M Cole, Miriam R Fernandes, Stephanie M Prescott, Raquel G F Costa, Ascharya K Balaji, Andrey Morgun, Ivan Vujkovic-Cvijin, Hong Wang, Amir A Borhani, Marc B Schwartz, Howard M Dubner, Scarlett J Ernst, Amy Rose, Yana G Najjar, Yasmine Belkaid, Joanne M Jeter, Giorgio Trinchieri, Hassane M Zarour
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science (New York, N.Y.) 371 (6529) (2021)